Nonlinear relationship between serum total bilirubin levels and initial ischemic stroke in patients with non-valvular

Ying Liu1, Jie Wang2,3, Wen-Zhen Zeng2

  • 1Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China.

Insights

Total bilirubin levels are linked to ischemic stroke risk in patients with non-valvular atrial fibrillation. Higher bilirubin may increase stroke risk, with an optimal level identified for the lowest risk.

Area of Science:

  • Cardiology
  • Neurology
  • Biochemistry

Background:

  • Non-valvular atrial fibrillation (NVAF) is a major risk factor for ischemic stroke.
  • Understanding biomarkers that predict stroke risk in NVAF patients is crucial for prevention.

Purpose of the Study:

  • To investigate the association between serum total bilirubin levels and the incidence of initial ischemic stroke in patients diagnosed with NVAF.

Main Methods:

  • Retrospective study design involving 316 NVAF patients.
  • Diagnosis of atrial fibrillation via 24-hour Holter ECG; ischemic stroke confirmed by clinical presentation and imaging.
  • Multivariate Cox proportional hazards and survival analyses were employed to assess the relationship between total bilirubin quintiles and stroke risk.

Main Results:

  • A total of 42 (13.29%) first ischemic strokes occurred during follow-up.
  • Each 1 µmol/L increase in total bilirubin was associated with a 4% rise in ischemic stroke risk (95% CI: 1.01, 1.07) after adjustment.
  • The lowest risk of ischemic stroke was observed at a total bilirubin level of 17.0 µmol/L.

Conclusions:

  • Serum total bilirubin levels exhibit a nonlinear association with the risk of initial ischemic stroke in patients with non-valvular atrial fibrillation.
  • These findings suggest total bilirubin may serve as a potential predictive biomarker for ischemic stroke in this patient population.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
98
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
626
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
2.6K